Arvida Scheme Implementation, Delisting and Board Appointments
NZX / Arvida Group
Publisher: NZX
Sector evidence
Sector body
August 2026
Next review not yet scheduled
New Zealand
High confidence
published
SNZ editorial review
Evidence boundary: This record summarises the cited source. It does not establish local availability, individual eligibility, or professional advice.
Short Answer
The NZX announcement records completion of Stonepeak's acquisition of Arvida Group, Arvida's delisting, and the associated board transition.
Key Points
- •Arvida's acquisition by Stonepeak was implemented on 20 November 2024.
- •Arvida delisted from the NZX following implementation of the scheme.
- •Bill McDonald was appointed an independent director and Chair on the same day.
- •The announcement is the primary transaction and appointment record for the meeting context.
Full Summary & Notes
The NZX announcement records completion of Stonepeak's acquisition of Arvida Group, Arvida's delisting, and the associated board transition. It is the primary source for Bill McDonald's current Arvida governance position used in the PiP meeting brief.
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
Evidence review of Arvida's outward-facing Good Friends model at Park Lane.
Competitive profile for PiP spanning resident technology, village operations, systems of record, operator-owned products and service navigation.
Sanitized post-meeting strategy brief that turns Ondine Claridge's provider-first direction into a verified HCSS opportunity assessment.
The audited summary report documents The Selwyn Foundation Group's village operations, community mission, advocacy, grantmaking, investment position and shift toward measurable social impact.
Opportunity thesis Selwyn Village is a credible potential PiP pilot environment, while The Selwyn Foundation is a separate potential social-impact and investment partner.
Public-source HCSS market map ranking provider and association outreach for a bounded non-clinical PiP pilot.